IMPACT OF CALCIUM ENTRY BLOCKERS ON GLOMERULAR INJURY IN EXPERIMENTAL-HYPERTENSION

被引：20

作者：

DWORKIN, LD

机构：

[1] Department of Medicine, New York University Medical Center, New York, 10016, NY

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 05期

关键词：

calcium antagonists; desoxycorticosterone-salt; glomerular hemodynamics; glomerular sclerosis; hypertension; kidney; remnant; renal hypertrophy;

D O I：

10.1007/BF02018259

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A major problem for patients with kidney disease and their physicians is that most chronic renal diseases progress to global glomerular sclerosis and end-stage renal failure. Studies in experimental models of hypertension and renal insufficiency have advanced our understanding of the pathogenesis of progressive kidney damage. In a number of settings, sclerosis has been related to the presence of intrarenal hypertension, a consequence of the hemodynamic adaptation to a reduction in the number of functioning nephrons. A growing body of evidence also supports the hypothesis that kidney and glomerular hypetrophy constitute an independent risk factor for glomerular sclerosis. Recent studies suggest that calcium antagonists can reduce glomerular injury in experimental hypertension. Renal protection may be related to the ability of these agents to inhibit compensatory renal growth. © 1990 Kluwer Academic Publishers.

引用

页码：1325 / 1330

页数：6

共 32 条

[11]

Anderson S., Rennke H.G., Brenner B.M., Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, pp. 1993-2000, (1986)

[12]

Dworkin L.D., Grosser M., Feiner H.D., Et al., The renal vascular effects of antihypertensive therapy in uninephrectomized spontaneously hypertensive rats, Kidney Int, 35, (1989)

[13]

Chanutin A., Ferris E.B., Experimental renal insufficiency produced by partial nephrectomy in control diet, Archives of Internal Medicine, 49, pp. 767-787, (1932)

[14]

Jobin J.R., Bonjour J.P., Compensatory renal growth: Modulation by calcium PTH and 1,25-(OH)<sub>2</sub>D<sub>3</sub>, Kidney Int, 29, pp. 1124-1130, (1986)

[15]

Hayslett J.P., Functional adaptation to reduction in renal mass, Physiol Rev, 59, pp. 137-164, (1979)

[16]

Anderson S., Meyer T.W., Rennke H.G., Brenner B.M., Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest, 76, pp. 612-619, (1985)

[17]

Meyer T.W., Anderson S., Rennke H.G., Brenner B.M., Reversing glomerular hypertension stabilizes established glomerular injury, Kidney Int, 31, pp. 751-759, (1987)

[18]

Dworkin L.D., Parker M., Feiner H.D., Nifedipine decreases glomerular injury in rats with remnant kidneys by inhibiting glomerular hypertrophy, Am Soc Neph, 21, (1988)

[19]

Harris D.H., Hammond W.S., Burke T.J., Schrier R.W., Verapamil protects against progression of experimental chronic renal failure, Kidney Int, 31, pp. 41-46, (1987)

[20]

Pelayo J.C., Harris D.C.H., Shanley P.F., Et al., Glomerular hemodynamic adaptations in remnant nephrons: Effects of verapamil, Am J Physiol, 254, (1988)

← 1 2 3 4 →